Inactive Instrument

All News Aquinox Pharmaceuticals Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
-	-

06-11	Baird Initiates Neurogene With Outperform Rating, $54 Price Target	MT
06-03	Neurogene's Gene Therapy For Rett Syndrome Picked For FDA Pilot Program	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Initiates Neurogene With Outperform Rating, $54 Price Target	06-11	MT
Neurogene to Participate in Upcoming Conferences	06-05	BU
Neurogene's Gene Therapy For Rett Syndrome Picked For FDA Pilot Program	06-03	MT
Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot Program	06-03	BU
Neurogene Inc. Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for Start Pilot Program	06-03	CI
Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates	05-13	AQ
Neurogene: Q1 Earnings Snapshot	05-10	AQ
Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates	05-10	BU
Neurogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
Neurogene : ASGCT NGN-401 Clinical Safety Poster	05-07	PU
Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual Meeting	05-07	BU
Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome During Asgct Annual Meeting	05-07	CI
Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target	04-29	MT
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting	04-22	BU
North American Morning Briefing : Stocks Struggle After New Records	03-22	DJ
William Blair Initiates Neurogene With Outperform Rating	03-21	MT
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates	03-18	BU
Neurogene Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI
North American Morning Briefing : Inflation -2-	03-15	DJ
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial	03-04	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Aquinox Pharmaceuticals Inc Nasdaq

Equities

All News

Filters